Camilla Bjørnbak Holst

University of Copenhagen — Denmark

Medicine · Health Sciences

9h-index463citations20works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(6), Studies on Chitinases and Chitosanases(6), Barrier Structure and Function Studies(3), Diet and metabolism studies(3), Cancer, Hypoxia, and Metabolism(2)

Publications20 total

Glucagon does not directly stimulate pituitary secretion of ACTH, GH or copeptin
Peptides·2024· 3 citedOpen Access
The <scp>HOPX</scp> and <scp>BLBP</scp> landscape and gliogenic regions in developing human brain
Journal of Anatomy·2023· 9 citedOpen Access
Glucagon Does Not Directly Stimulate Pituitary Secretion of Acth, Gh or Copeptin
SSRN Electronic Journal·2023Open Access
Perspective: targeting VEGF-A and YKL-40 in glioblastoma – matter matters
Cell Cycle·2021· 13 citedOpen Access
Plasma IL-8 and ICOSLG as prognostic biomarkers in glioblastoma
Neuro-Oncology Advances·2021· 14 citedOpen Access
Perspective: targeting VEGF-A and YKL-40 in glioblastoma – matter matters
Figshare·2021Open Access
Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40
Frontiers in Oncology·2020· 17 citedOpen Access
EPID-06. IMMUNE-RELATED PLASMA BIOMARKERS IN GLIOBLASTOMA
Neuro-Oncology·2019Open Access
Astrogliogenesis in human fetal brain: complex spatiotemporal immunoreactivity patterns of <scp>GFAP</scp>, S100, <scp>AQP</scp>4 and <scp>YKL</scp>‐40
Journal of Anatomy·2019· 72 citedOpen Access
Author Correction: BRCA1-regulated RRM2 expression protects glioblastoma cells from endogenous replication stress and promotes tumorigenicity
Nature Communications·2018· 7 citedOpen Access
Outcome of Bevacizumab Therapy in Patients with Recurrent Glioblastoma Treated with Angiotensin System Inhibitors
Cancer Investigation·2018· 12 citedOpen Access
Plasma YKL-40 as a biomarker for bevacizumab efficacy in patients with newly diagnosed glioblastoma in the phase 3 randomized AVAglio trial
Oncotarget·2017· 20 citedOpen Access
Brain barriers and functional interfaces with sequential appearance of ABC efflux transporters during human development
Scientific Reports·2017· 67 citedOpen Access
BRCA1-regulated RRM2 expression protects glioblastoma cells from endogenous replication stress and promotes tumorigenicity
Nature Communications·2016· 125 citedOpen Access
P08.15 Impact of renin-angiotensin system blockade on clinical outcome in glioblastoma patients
Neuro-Oncology·2016Open Access
ANGI-15COMBINED TARGETING OF NOTCH AND EGFR DISPLAY ADDITIVE INHIBITORY EFFECTS ON ANGIOGENESIS AND SURVIVAL IN GLIOBLASTOMA
Neuro-Oncology·2015Open Access
ANGI-05CORRELATION BETWEEN VEGF AND YKL-40 TISSUE EXPRESSION AND PLASMA LEVELS IN GLIOBLASTOMA
Neuro-Oncology·2015Open Access
Abstract 4306: A prognostic model for clinical response to bevacizumab in recurrent glioblastoma multiforme
Cancer Research·2015
Outer brain barriers in rat and human development
Frontiers in Neuroscience·2015· 104 citedOpen Access
334 INVITED Are There Early Common Origins of Obesity, Diabetes and Cancer?
European Journal of Cancer·2011

Frequent Co-authors

Hans Skovgaard Poulsen(10), Petra Hamerlik(9), Kjeld Møllgård(8), Julia S. Johansen(7), Kristoffer Vitting‐Seerup(5), Ib Jarle Christensen(5), Kamilla E. Jensen(4), Jane Skjøth‐Rasmussen(4), Christian Beltoft Brøchner(3), Eva Løbner Lund(3), Thomas Urup(3), Rikke Rasmussen(2), Madhavsai Gajjar(2), Lucie Tučková(2), Apolinar Maya‐Mendoza(2), Jane S. Rasmussen(2), Jannick Brennum(2), Martin Syrůček(2), Eva Sedlákova(2), Klaus K. Andersen(2)